Childhood/AYA Cancer

FDA Approves Radiopharmaceutical Diagnostic Agent for Pediatric Patients

June 10, 2021

The FDA approved injectable technetium Tc 99m tilmanocept (Lymphoseek), a radiopharmaceutical agent that targets lymphatic mapping and guiding for sentinel lymph node biopsies (SLNB), for use in pediatric patients with melanoma, rhabdomyosarcoma, and other solid tumors.